Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03845504 · ClinicalTrials.gov registry record · NA
iTBS in Refractory Pediatric Depression
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03845504: Clinical Trial NA study, sponsored by Stanford University.
NCT03845504 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03845504, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This work will mark the first step in understanding the neural targets for rTMS in youth with difficult to treat depressive symptoms, creating benchmarks for optimizing the safety and efficacy of rTMS for pediatric populations through precision targeting, and encourage funding applications for larger sham- controlled randomized clinical studies.
Primary Outcome
Standardized assessment to determine depression severity. The CDRS-R total score is the sum of the responses to 17 questions. Each question is graded on a 5- or 7-point scale. Total score ranges from 17-113. In general, higher values of CDRS-R total score represent greater severity of illness. Response to treatment is determined by a ≥ 50% reduction in score from baseline to end of treatment.
Interventions
- DEVICE Intermittent Theta Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2019-10-09 |
| Phase | NA |
Why NCT03845504 stopped before completion
NCT03845504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Intermittent Theta Burst Stimulation is the first listed.
NCT03845504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03845504 about?
NCT03845504 is a clinical study titled "iTBS in Refractory Pediatric Depression". This work will mark the first step in understanding the neural targets for rTMS in youth with difficult to treat depressive symptoms, creating benchmarks for optimizing the safety and efficacy of rTMS for pediatric populations through precision targeting, and encourage funding applications for large...
What is the current status of trial NCT03845504?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-11-19. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT03845504?
The interventions under investigation include: Intermittent Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03845504?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03845504's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI